Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.
Most participants first33,758 with no events in either group come last161 to 180 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| Ovarian Screening vs Control: Deaths From All Causes | 3,508 of 34,253 3,542 of 34,304 | -0.1 points -0.5 to 0.4 | 68,557 | NCT01696994 Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) |
| Intervention vs Control Arm: deaths from any cause | 608 of 43,054 380 of 25,088 | -0.1 points -0.3 to 0.1 | 68,142 | NCT04570371 Non-pharmacological Pain Management After Surgery |
| Intervention vs Control Arm: serious adverse events | 104 of 43,054 25 of 25,088 | 0.1 points 0.1 to 0.2 | 68,142 | NCT04570371 Non-pharmacological Pain Management After Surgery |
| RotaTeq™ vs Placebo: Intussusception Within 42 Days Following Any Dose of RotaTeq™/Placebo | 6 of 34,002 5 of 33,969 | 0.0 points -0.0 to 0.0 | 67,971 | NCT00090233 Rotavirus Efficacy and Safety Trial (REST)(V260-006) |
| Azithro vs Placebo: deaths from any cause | 1,493 of 33,173 1,584 of 33,055 | -0.3 points -0.6 to 0.0 | 66,228 | NCT03338244 Mortality Reduction After Oral Azithromycin Contingency: Mortality Study |
| PCV13-vaccinated Participants vs Unvaccinated Participants: VE for First Event of ACP at 5-7 Years of Follow-up | 1,200 of 25,890 1,757 of 40,301 | 0.3 points -0.0 to 0.6 | 66,191 | NCT05794191 A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV |
| Olodaterol vs Other Long-acting beta2-agonist (LABAs): deaths from any cause | 859 of 14,239 1,872 of 51,167 | 2.4 points 2.0 to 2.8 | 65,406 | NCT03405363 Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists |
| Text-Messaging (TM) vs Text-Messaging Plus Patient Navigation: Uptake-Total | 14,308 of 32,594 14,381 of 32,706 | -0.1 points -0.8 to 0.7 | 65,300 | NCT04939519 SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers |
| Text-Messaging (TM) vs Text-Messaging Plus Patient Navigation: Reach-TM Engage | 5,538 of 32,594 5,587 of 32,706 | -0.1 points -0.7 to 0.5 | 65,300 | NCT04939519 SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers |
| SMART-AI vs Usual Care: Proportion of Patients That Had a Universal Screen Positive and Received SBIRT (Screening, Brief Intervention, or Referral to Treatment) | 1,144 of 33,564 1,189 of 31,432 | -0.4 points -0.7 to -0.1 | 64,996 | NCT03833804 Data-driven Identification for Substance Misuse |
| SMART-AI vs Usual Care: All-cause Re-hospitalizations Following 6-months From the Index Hospital Encounter | 10,241 of 33,564 9,584 of 31,432 | 0.0 points -0.7 to 0.7 | 64,996 | NCT03833804 Data-driven Identification for Substance Misuse |
| Anesthesia Control Tower Monitoring vs Standard of Care Arm: Blood Glucose Management | 1,848 of 32,437 1,786 of 32,435 | 0.2 points -0.2 to 0.5 | 64,872 | NCT03923699 Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety |
| Hp Stool Antigen (HpSA)+FIT vs FIT Only: Incidence of Stomach Cancer | 49 of 31,497 59 of 31,777 | -0.0 points -0.1 to 0.0 | 63,274 | NCT01741363 Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing |
| Hp Stool Antigen (HpSA)+FIT vs FIT Only: Mortality of Stomach Cancer | 17 of 31,497 23 of 31,777 | -0.0 points -0.1 to 0.0 | 63,274 | NCT01741363 Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing |
| Standardized Intervention vs Control: deaths from any cause | 599 of 31,493 582 of 31,519 | 0.1 points -0.2 to 0.3 | 63,012 | NCT02621476 Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities |
| Empagliflozin Initiators vs Dipeptidyl Peptidate-4 Inhibitor (DPP4i) Initiators: deaths from any cause | 341 of 20,279 1,528 of 41,918 | -2.0 points -2.2 to -1.7 | 62,197 | NCT05465317 Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease |
| LNG IUS vs Copper IUD: Contraceptive Failure | 26 of 43,078 92 of 18,370 | -0.4 points -0.6 to -0.3 | 61,448 | NCT00461175 European Active Surveillance Study for Intrauterine Devices |
| LNG IUS vs Copper IUD: Uterine Perforation Rate | 61 of 43,078 20 of 18,370 | 0.0 points -0.0 to 0.1 | 61,448 | NCT00461175 European Active Surveillance Study for Intrauterine Devices |
| LNG IUS vs Copper IUD: serious adverse events | 21 of 43,078 7 of 18,370 | 0.0 points -0.0 to 0.0 | 61,448 | NCT00461175 European Active Surveillance Study for Intrauterine Devices |
| CONCERN Intervention Group vs Usual Care Group: deaths from any cause | 181 of 33,024 265 of 27,869 | -0.4 points -0.5 to -0.3 | 60,893 | NCT03911687 (CONCERN) Clinical Decision Support (CDS) System |
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=9
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT01696994-f8dc1c23",
"title": "Ovarian Screening vs Control: Deaths From All Causes",
"summary": "3508 of 34253 against 3542 of 34304; risk difference -0.1 points, 95% interval -0.5 to 0.4; NCT01696994, Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)",
"record": "/library/comparisons/NCT01696994-f8dc1c23",
"nct_id": "NCT01696994",
"kind": "outcome",
"participants": 68557,
"risk_difference": {
"value": -0.000838877864385773,
"lower": -0.005386793512808159,
"upper": 0.003709083948153502
},
"group_1": "3,508 of 34,253",
"group_2": "3,542 of 34,304",
"difference": "-0.1 points",
"interval": "-0.5 to 0.4",
"trial_title": "Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)"
},
{
"id": "NCT04570371-deaths",
"title": "Intervention vs Control Arm: deaths from any cause",
"summary": "608 of 43054 against 380 of 25088; risk difference -0.1 points, 95% interval -0.3 to 0.1; NCT04570371, Non-pharmacological Pain Management After Surgery",
"record": "/library/comparisons/NCT04570371-deaths",
"nct_id": "NCT04570371",
"kind": "deaths",
"participants": 68142,
"risk_difference": {
"value": -0.0010248831439018669,
"lower": -0.002940236605468309,
"upper": 0.0008224731664002714
},
"group_1": "608 of 43,054",
"group_2": "380 of 25,088",
"difference": "-0.1 points",
"interval": "-0.3 to 0.1",
"trial_title": "Non-pharmacological Pain Management After Surgery"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "None stated"
}
],
"next": "/api/comparisons/v1?page=10",
"request_id": "Luy9gACJM4Tw2aRv"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant